⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NTRB News
Nutriband Inc. Common Stock
Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $1,753,274
globenewswire.com
NTRB
Nutriband Files New Patent Application to Strengthen Intellectual Property Protection of Its Transdermal Abuse Deterrent Technology
globenewswire.com
NTRB
Nutriband Marks Five Years on Nasdaq – CEO Letter to Shareholders
globenewswire.com
NTRB
Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis
globenewswire.com
NTRB
NTRBW
Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board
globenewswire.com
NTRB
NTRBW
Form 8-K
sec.gov
NTRB
NTRBW
Nutriband Confirms Warrants Will Expire September 30 Without Extension or Repricing
globenewswire.com
NTRB
NTRBW
Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit
globenewswire.com
NTRB
NTRBW
Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch
globenewswire.com
NTRB
NTRBW
Nutriband CEO, Gareth Sheridan to Present at the 2026 Georgia Life Sciences Summit as Part of the CEO Spotlight
globenewswire.com
NTRB
NTRBW